Evidence map›Paper›PMID 19472344›Full record

ArticleProtein science : a publication of the Protein Society2009

Design, generation, and testing of mammalian expression modules that tag membrane proteins.

John Pang, Xiaokun Zeng, Rui-ping Xiao, Edward G Lakatta, Li Lin

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John PangLaboratory of Cardiovascular Sciences, National Institute on Aging, National Institute of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA.
Xiaokun Zeng
Rui-ping Xiao
Edward G Lakatta
Li Lin

Funding

Soluble Receptor for Advanced Glycation End Products for Therapeutic ApplicationZIAAG000875 · NIA · NATIONAL INSTITUTE ON AGING · PI LAKATTA, EDWARD · 2009 to 2016
$1.9M
Use p105(sr) to study p50 homodimer in skin tumor/cancerR01CA104912 · NCI · MEDSTAR RESEARCH INSTITUTE · PI LIN, LI · 2005 to 2009
$1.1M
Intramural NIH HHSNCI NIH HHS R01 CA 104912
6 · The paper itself

Abstract

The expression of mammalian membrane proteins in laboratory cell lines allows their biological functions to be characterized and carefully dissected. However, it is often difficult to design and generate effective antibodies for membrane proteins in the desired studies. As a result, expressed membrane proteins cannot be detected or characterized via common biochemical approaches such as western blotting, immunoprecipitation, or immunohistochemical analysis, and their cellular behaviors cannot be sufficiently investigated. To circumvent such roadblocks, we designed and generated two sets of expression modules that consist of sequences encoding for three essential components: (1) a signal peptide from human receptor for advanced glycation end products that targets the intended protein to the endoplasmic reticulum for cell surface expression; (2) an antigenic epitope tag that elicits specific antibody recognition; and (3) a series of restriction sites that facilitate subcloning of the target membrane protein. The modules were designed with the flexibility to change the epitope tag to suit the specific tagging needs. The modules were subcloned into expression vectors, and were successfully tested with both Type I and Type III human membrane proteins: the receptor for advanced glycation end products, the Toll-like receptor 4, and the angiotensin II receptor 1. These expressed membrane proteins are readily detected by western blotting, and are immunoprecipitated by antibodies to their relative epitope tags. Immunohistochemical and biochemical analyses also show that the expressed proteins are located at cell surface, and maintain their modifications and biological functions. Thus, the designed modules serve as an effective tool that facilitates biochemical studies of membrane proteins.

Indexed as

Protein BiosynthesisCell LineCell MembraneEpitopesGenetic VectorsHumansMembrane ProteinsReceptor, Angiotensin, Type 1Receptor for Advanced Glycation End ProductsReceptors, ImmunologicRecombinant Fusion ProteinsToll-Like Receptor 4TransfectionEpitopesMembrane ProteinsReceptor, Angiotensin, Type 1Receptor for Advanced Glycation End ProductsReceptors, ImmunologicRecombinant Fusion ProteinsTLR4 protein, humanToll-Like Receptor 4

Identifiers

PMID19472344
PMCPMC2774436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.